Lake Como 2|4 October 2011 - CHIMICA Oggi/Chemistry Today

AGENDA
MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY MONDAY
OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT OCT 33
33
33
33
33
33
33
33
33
33
33
33
33
33
33
33
33
33
33
33
33
3
8:30-9:00 Registration
9:00-9:15 Welcome
KEY NOTE LECTURE
9:15-10:00 Ian Baxendale - University of Cambridge - “Chemical
synthesis and processing using fl ow reactors”
CASE STUDIES - SESSION I
10:00-10:05 Session introduction
10:05-10:35 Giorgio Borghi - Matric Europa - “The advantages of
continuous production of specialty chemicals enabled by
fl ow chemistry”
10.35-10:55 Franz Amann - Dishman Group - “Ozonolysis in a micro
reactor system”
10:55-11:25 COFFEE BREAK + POSTERS + EXHIBITION
11:25-11:55 Gilda Gasparini - AM Technology - “Scaling up fl ow
reactors” (Biotech case study)
11.55-12:25 Oliver Kappe - University of Graz - “Challenges and
opportunities in large scale microwave fl ow chemistry”
12:30-13.15 LUNCH BREAK
13:15 – 14:00 COFFEE BREAK + POSTERS + EXHIBITION
CASE STUDIES - SESSION II
14:00-14:30 Wenting Chen - Beijing Laviana Pharmatech Co., Ltd -
“Continuous fl ow reactor: A platform toward the green
manufacturing”
14:30-15.00 Barry Johnson - Alfa Laval Ltd - “Achieving production
scale fl ow chemistry”
15:00-15.30 Discussion
15.30-16:00 COFFEE BREAK + POSTERS + EXHIBITION
REGULATION SESSION
16.00-16:05 Session introduction
16:05-16:35 Peter Poechlauer - DSM Fine Chemicals - “From batch
to continuous: a ‘quality by design’ approach to handle
hazardous materials in api manufacture”
16.:35-17:05 Nigel A. Fletcher - Foster Wheeler Energy Ltd - “Successful
achievement of regulatory compliance and continuous
pharmaceutical processing”
17:05-17:35 Christine Moore - FDA - “Continuous manufacturing - FDA
perspective on submissions and implementation”
17:35-18:00 Discussion
18:00 Conclusion fi rst day
19:00 Gala dinner
1
Lake Como
2|4 October 2011